Stockreport

ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

ENDRA Life Sciences Inc.  (NDRA) 
PDF TAEUS Liver demonstrates strong agreement with the industry’s imaging gold standard, MRI-PDFF, across the full spectrum of steatotic liver disease and patient BMI ANN [Read more]